top of page
Glioma Banner 3

HISTOLOGY IN UNDER 3 MINUTES

Fresh Tissue Imaging with the NIO Laser Imaging System 

"Stimulated Raman Histology has the potential to revolutionize digital pathology, giving us the ability to view cellular features and architecture in real time and provide immediate feedback to our surgery colleagues."

- Dr. Matija Snuderl, Neuropathologist

Invenio Imaging Celebrates 2000th NIO Laser Imaging System case | PR Newswire | Oct 12, 2021

Streamlined Workflow for On-site Tissue Evaluation

Slide with biopsy on it_target2.png

EASY SAMPLE PREPARATION

NEAR REAL-TIME INTRAOPERATIVE IMAGING

NIO Slide enables sample prep without staining or sectioning by existing OR staff.

NIO Imaging System delivers high-quality images in 3 minutes or less.

NIO Ambra Integration

DIGITAL IMAGE SHARING AND ARCHIVING

NIO images are natively digital and can be shared with existing IT infrastructure via a vendor-neutral DICOM interface.

20104-1.png

SPECIMEN RETRIEVAL AND DOWNSTREAM ANALYSIS

NIO Slides allow sample retrieval for downstream analysis after imaging.

“We want to be able to analyze lung tissue intraoperatively without losing the sample for downstream analysis. The beauty of SRH is that it renders tissue reusable, allowing thoracic pathologists to conduct additional studies with the sample.”

- Dr. Jamie Bessich, Interim Section Chief, Interventional Pulmonology, NYU Langone Health

Raman Spectroscopy Aids Detection of Lung Cancers | NYU Physician Focus | Pulmonology and Lung Surgery

Discover How NIO is Used Throughout Surgical Subspecialties

Neuro.png
Sin título-5.png

Neurosurgery

brain icon.png
Sin título-5.png

Interventional Pulmonology

lung icon.png

Urology

bladder icon.png
Sin título-5.png

Ear, Nose & Throat (ENT)

Captura de pantalla 2024-05-21 a las 11.17.23.png

Breast Oncology

breast icon.png
pdac.png

GI Endoscopy

Nephrology screenshot

Organ Transplantation

Artificial Intelligence at the Time of Surgery

NIO Glioma Reveal is the first clinical image analysis algorithm based on deep learning that allows neurosurgeons to identify areas of cancer infiltration in patients undergoing primary treatment of a diffuse glioma. Neurosurgeons in the European Union can now use NIO Glioma Reveal to inform intraoperative decisions. NIO Glioma Reveal is available "For Research Use Only" in the United States, not for use in diagnostic procedures.

NIO Glioma Reveal.JPG

"Glioma Reveal provides cancer detection where we really need it, dramatically improving brain tumor surgery."

bottom of page